Genmab — Februar 2024
-
ud i det blå - 9% cagr for en virksomhed der bryster sig af at være noget særligt....
-
???
-
If you can't dazzle them with brilliance, baffle them with bullshit.
-
en refleksion over dit ret så uforståelige oeuvre - men det overrasker mig ikke, at du går den vej
-
gentialt. så kan det være, at vi kan få banket lidt facts ind i solsen
-
I er fulde af vittige replikker i dag - kommer i alle fra samme skole: https://www.pinterest.com/pin/midvale-school-for-the-gifted--416723771780044122/
-
aaah - det er roi siden ipo på aktien. Det burde jeg nok have specificeret
-
-
har du kigget på sidste sætning? Lyder det ikke som et selskab vi kender?
-
men absolut interessant
-
sorry - der var mere efter reklamen - men det var denne sætning "The focus of the campus was emerging gene and RNA-based therapies, plus research on retinal and infectious diseases. "
-
mon de tænker, at covid og den slags er bag os, så det skal der ikke investeres i? Tidligere var der også en slet skjult foragt for RNA terapier i videnskabelige kredse
-
https://www.jnj.com/media-center/press-releases/johnson-johnson-opens-state-of-the-art-science-and-technology-campus-in-san-francisco-bay-area “ The R&D focus at the new site spans Janssen’s therapeutic areas and key functions”
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind